Shanghai’s Fosun Pharma inks agreement to supply 10 million doses of Covid-19 vaccine to Hong Kong and Macau once approved

Fosun earlier obtained the licence from Mainz-based BioNTech to exclusively develop and commercialise its mRNA Covid-19 vaccine products in China.
( read original story …)

---